Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/aje/kwy190 | DOI Listing |
Transgenic Res
January 2025
Faculty of Food and Nutritional Sciences, Toyo University, 48-1 Oka, Asaka-shi, Saitama, 351-8510, Japan.
The environmental risk assessment (ERA) of genetically modified (GM) crops in Japan requires collecting data from a comparative study of a GM and non-GM control in an in-country confined field trial (CFT). This in-country CFT requirement is used to address concerns that differences in the local environmental conditions may lead to differences in growth and/or risks of GM crops. However, this requirement for in-country CFT has recently been exempted for certain GM maize and GM cotton traits, and instead CFT data from other countries are used to inform the ERA of these GM events.
View Article and Find Full Text PDFAm J Epidemiol
December 2024
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore MD.
The Systolic Blood Pressure Intervention Trial (SPRINT) estimated the effect of intensive SBP treatment (target <120 mmHg) compared to standard (<140 mmHg) on the risk of cardiovascular events in adults aged 50+ years. Clinical trial participants may differ from an intervention's target population. We generalized the SPRINT results to U.
View Article and Find Full Text PDFJAMA Netw Open
December 2024
Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.
Public Health Res (Southampt)
December 2024
Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Background: Children and young people with experience of being in care (e.g. foster care, kinship care, residential care or at home with a supervision requirement order) are at higher risk of adverse mental health and well-being outcomes compared to the general population.
View Article and Find Full Text PDFHealth Econ
January 2025
Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK.
Methods have been developed for transporting evidence from randomised controlled trials (RCTs) to target populations. However, these approaches allow only for differences in characteristics observed in the RCT and real-world data (overt heterogeneity). These approaches do not recognise heterogeneity of treatment effects (HTE) according to unmeasured characteristics (essential heterogeneity).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!